Learn About Neuromyelitis Optica

What is the definition of Neuromyelitis Optica?

Neuromyelitis optica is an autoimmune disorder that affects the nerves of the eyes and the central nervous system, which includes the brain and spinal cord. Autoimmune disorders occur when the immune system malfunctions and attacks the body's own tissues and organs. In neuromyelitis optica, the autoimmune attack causes inflammation of the nerves, and the resulting damage leads to the signs and symptoms of the condition.

What are the causes of Neuromyelitis Optica?

No genes associated with neuromyelitis optica have been identified. However, a small percentage of people with this condition have a family member who is also affected, which indicates that there may be one or more genetic changes that increase susceptibility. It is thought that the inheritance of this condition is complex and that many environmental and genetic factors are involved in the development of the condition.

How prevalent is Neuromyelitis Optica?

Neuromyelitis optica affects approximately 1 to 2 per 100,000 people worldwide. Women are affected by this condition more frequently than men.

Is Neuromyelitis Optica an inherited disorder?

Neuromyelitis optica is usually not inherited. Rarely, this condition is passed through generations in families, but the inheritance pattern is unknown.

Who are the top Neuromyelitis Optica Local Doctors?
Experienced in Neuromyelitis Optica
Experienced in Neuromyelitis Optica

Ou Health Partners Inc

825 Ne 10th St, Ouhp Ou Physicians Building, 
Oklahoma City, OK 
 (38.4 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Evgeny Sidorov is a Neurologist in Oklahoma City, Oklahoma. Dr. Sidorov and is rated as an Experienced provider by MediFind in the treatment of Neuromyelitis Optica. His top areas of expertise are Stroke, Sporadic Hemiplegic Migraine, Familial Hemiplegic Migraine, Thrombectomy, and Gastrostomy. Dr. Sidorov is currently accepting new patients.

Distinguished in Neuromyelitis Optica
Neurology | Ophthalmology
Distinguished in Neuromyelitis Optica
Neurology | Ophthalmology

Oklahoma Medical Research Foundation

825 Ne 13th St, 
Oklahoma City, OK 
 (38.7 mi)
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Gabriel Pardo is a Neurologist and an Ophthalmologist in Oklahoma City, Oklahoma. Dr. Pardo and is rated as a Distinguished provider by MediFind in the treatment of Neuromyelitis Optica. His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Optic Neuritis, and Neuromyelitis Optica. Dr. Pardo is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Neuromyelitis Optica
Advanced in Neuromyelitis Optica

Ou Health Partners Inc

900 Ne 10th St, Ouhp Family Medicine, 
Oklahoma City, OK 
 (38.4 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Nidhiben Anadani is a Neurologist in Oklahoma City, Oklahoma. Dr. Anadani and is rated as an Advanced provider by MediFind in the treatment of Neuromyelitis Optica. Her top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Neuromyelitis Optica, and Optic Neuritis. Dr. Anadani is currently accepting new patients.

What are the latest Neuromyelitis Optica Clinical Trials?
French Registry for Monitoring Pregnancies and Children of Women with Multiple Sclerosis Within the Observatoire Français De La Sclérose En Plaque (OFSEP) Cohort

Summary: The influence of pregnancy on the course of multiple sclerosis (MS) has long been a controversial topic. After the publication of the first large prospective study of pregnancy and MS in 1998, counselling of women with MS has radically changed and many patients have been able to fulfill their desire of motherhood. However, there are still some challenges for the neurologist, who has to face old un...

Match to trials
Find the right clinical trials for you in under a minute
Get started
An Observational Pregnancy Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® (Inebilizumab-cdon) During Pregnancy

Summary: This is an observational study to monitor female participants exposed to UPLIZNA during pregnancy. This study requires voluntary reporting of pregnancies in female participants with NMOSD exposed to UPLIZNA during pregnancy or within 6 months preceding conception. Pregnancy-related data, potential confounding factors and information related to pregnancy outcome will be collected. The schedule of o...

Who are the sources who wrote this article ?

Published Date: March 01, 2015
Published By: National Institutes of Health